Filter
912
Text search:
University
of
Malawi
Featured
70
182
Language
Document type
505
225
84
54
22
11
7
2
1
Countries / Regions
85
41
40
31
31
25
24
22
14
13
12
12
11
11
11
10
10
9
9
8
7
7
7
7
7
6
6
5
5
4
4
4
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
316
89
72
57
38
14
8
Toolboxes
116
91
60
43
42
36
34
31
28
18
17
15
13
11
10
7
6
5
5
5
4
3
2
1
Trials (2017) 18:152, DOI 10.1186/s13063-017-1881-z
This document contains: The systematic reviews and GRADE assessments used at the Index-TB Guideline Panel in July 2015; The Evidence to Decision tables that record the Panel’s assessment and recommendations from
this meeting
Поэтому уже давно возникала мысль о том,что подробный комментарий по вопросам научных знаний и практическогоопыта, лежащих в основе политики ВОЗ по борьбе
...
Глобальными приоритетами для лечения туберкулеза (ТБ) и борьбы с ним являются улучшенное и ранее выявление случаев туберкулеза, в том числе случаев заболевания с о
...
WHO working group on HIV incidence assays meeting report
10–11 December 2015
Glion, Switzerland
UNAIDS/WHO working group on global HIV/AIDS and STI surveillance
WHO/HIV/2017.03
COVID Reference 2021.6 EN
recommended
6th edition 13 January 2021 CR 2021.6.10, uploaded on 27 May 2021
Find eight editions: Deutsch | English | Español | Français | Italiano | Português | Tiếng Việt | Türkçe
https://covidreference.com/download
A paper presented during a conference on The Catholic Social Teaching and its Social and Political impact on the Development 9thto 10th December, in Schloss Eichholz Koln/Cologne/GermanyPresented by Sr. Dr. Elizabeth Nduku
accessed July 2020
La méningite est mortelle et débilitante ; elle frappe brutalement ; elle a de graves conséquences sanitaires, économiques et sociales et touche tous les âges de la vie dans tous les pays du monde. La méningite bactérienne peut être à l’origine d’épidémies, entraîner la mort dans les
...
Palliative care has been shown to provide significant and diverse benefits for patients with serious, complex,or life-limiting health problem.
Jamison DT, Gelband H, Horton S, Jha P, Laxminarayan R, Mock CN, Nugent R., editors. Disease Control Priorities, 3rd Edition,
Volume 9: Improving Health an
...
Preferred product characteristics and clinical development considerations
